A chicken-breast dipeptide called anserine just posted a surprisingly clean result in people with mild cognitive impairment. In a 12-week randomized trial, 500 mg a day lifted MMSE scores by about 1.9 points while placebo stayed flat (p=0.036). The proposed mechanism involves scavenging hypochlorous acid, a reactive molecule tied to neuroinflammation. It fits with earlier carnosine blend studies and a 2024 meta-analysis showing better delayed recall. But with just 30 people analyzed and one cognitive test, here is what the data does and does not tell you.
This page is available in